OACCNasdaqBlank ChecksFiscal year ends December 31Also trades as OACCU, OACCW

Oaktree Acquisition Corp. III Life Sciences

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026

$10.65−0.05 (-0.47%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): –
Dividend yield: –

Oaktree Acquisition Corp. III Life Sciences revenue by segment

No segment breakdown reported

Oaktree Acquisition Corp. III Life Sciences does not break out revenue by segment, region or product in the tagged data of its filings for this period type.